Generic Drug Name: Methotrexate Injection USP
Brand Name: PV METHO
Indications and Usage:
Methotrexate is indicated in the treatment of gestational choriocarcinoma, chorioadenoma destruents and hydatidiform mole. In acute lymphocytic leukemia, methotrexate is indicated in the prophylaxis of meningeal leukemia and is used in maintenance therapy in combination with other chemotherapeutic agents. Methotrexate is also indicated in the treatment of meningeal leukemia. Methotrexate is used alone or in combination with other anticancer agents in the treatment of breast cancer, epidermoid cancers of the head and neck, advanced mycosis fungoides (cutaneous T cell lymphoma), and lung cancer, particularly squamous cell and small cell types. Methotrexate is also used in combination with other chemotherapeutic agents in the treatment of advanced stage non-Hodgkin’s lymphomas.
Certification: WHO-GMP & WHO-GDP
Product Type: Finished Product
Following information is meant for: Wholesalers, Suppliers, Importers, Doctors, CROs, Hospitals, MOH Tender Supplies, NGOs and Institutional Buyers.
Description: Each Vial contains Methotrexate Injection USP
Strength: 5mg/2ml, 15mg/3ml, 50mg/2ml, 100mg/4ml, 1000mg/40ml
Pack Size: Single Vial
Pack Insert: Yes
Storage & Handling: Store below 30°C
PROTECT FROM LIGHT.
Retain in carton until time of use. Discard any unused portion.
PV Pharma Healthcare Pvt. Ltd. is WHO GMP/WHO GDP Certified Pharmaceutical Manufacturer & Exporter of Methotrexate Injection USP known as PV METHO. It is available in strength of 5mg/2ml, 15mg/3ml, 50mg/2ml, 100mg/4ml, 1000mg/40ml. This product is supplied for Tenders, Emergency imports, Un – licensed Medicines & Orphan drug.